{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:49:21Z","timestamp":1791416961646,"version":"4.3.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Project of NINGBO Leading Medical &Health Discipline","award":["2026-A41"],"award-info":[{"award-number":["2026-A41"]}]},{"name":"Zhejiang Science and Technology Plan for Disease Prevention and Control","award":["2026JKZ057"],"award-info":[{"award-number":["2026JKZ057"]}]},{"name":"Zhejiang Science and Technology Plan for Disease Prevention and Control","award":["2025JK269"],"award-info":[{"award-number":["2025JK269"]}]},{"name":"Ningbo Top Medical and Health Research Program","award":["2023020713"],"award-info":[{"award-number":["2023020713"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-28479-7","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:47:09Z","timestamp":1783579629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness of concurrently available oral and long-acting injectable pre-exposure prophylaxis for preventing HIV infections among men who have sex with men in eastern China: A modelling study"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhixin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1415-6762","authenticated-orcid":false,"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengsheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"28479_CR1","unstructured":"UNAIDS, Global HIV. & AIDS statistics \u2014 Fact sheet. 2025; https:\/\/www.unaids.org\/en\/resources\/fact-sheet. Accessed 1 Feb 2026."},{"issue":"48","key":"28479_CR2","first-page":"1249","volume":"6","author":"F Lyu","year":"2024","unstructured":"Lyu F. Prioritizing the People in HIV Prevention: Transforming Data into Effective Policies and Actions. China CDC Wkly. 2024;6(48):1249\u201350.","journal-title":"China CDC Wkly"},{"issue":"48","key":"28479_CR3","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.46234\/ccdcw2021.249","volume":"3","author":"N He","year":"2021","unstructured":"He N. Research Progress in the Epidemiology of HIV\/AIDS in China. China CDC Wkly. 2021;3(48):1022\u201330.","journal-title":"China CDC Wkly"},{"issue":"03","key":"28479_CR4","first-page":"253","volume":"32","author":"Prevention CCfDCa","year":"2026","unstructured":"Prevention CCfDCa. National HIV\/AIDS and STD Epidemic Situation in December 2025. Chin J AIDS STD. 2026;32(03):253.","journal-title":"Chin J AIDS STD"},{"issue":"2","key":"28479_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10461-018-2205-3","volume":"23","author":"L Zhang","year":"2019","unstructured":"Zhang L, Peng P, Wu Y, et al. Modelling the Epidemiological Impact and Cost-Effectiveness of PrEP for HIV Transmission in MSM in China. AIDS Behav. 2019;23(2):523\u201333.","journal-title":"AIDS Behav"},{"issue":"12","key":"28479_CR6","doi-asserted-by":"publisher","first-page":"e807","DOI":"10.1016\/S2352-3018(24)00212-1","volume":"11","author":"A Carter","year":"2024","unstructured":"Carter A, Zhang M, Tram KH, et al. Global, regional, and national burden of HIV\/AIDS,1990\u20132021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021. Lancet HIV. 2024;11(12):e807\u201322.","journal-title":"Lancet HIV"},{"issue":"10013","key":"28479_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","volume":"387","author":"S McCormack","year":"2015","unstructured":"McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet (London England). 2015;387(10013):53\u201360.","journal-title":"Lancet (London England)"},{"issue":"6","key":"28479_CR8","doi-asserted-by":"publisher","first-page":"e529","DOI":"10.1016\/S2468-2667(22)00106-2","volume":"7","author":"H Jourdain","year":"2022","unstructured":"Jourdain H, de Gage SB, Desplas D, Dray-Spira R. Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control study. Lancet Public Health. 2022;7(6):e529\u201336.","journal-title":"Lancet Public Health"},{"issue":"10","key":"28479_CR9","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1007\/s10461-024-04420-0","volume":"28","author":"L Wang","year":"2024","unstructured":"Wang L, Hong C, Chen L, et al. Engagement Along the PrEP Care Continuum Among Men Who Have Sex with Men in China: A Systematic Review and Meta-analysis. AIDS Behav. 2024;28(10):3270\u201382.","journal-title":"AIDS Behav"},{"issue":"9","key":"28479_CR10","doi-asserted-by":"publisher","first-page":"e1636","DOI":"10.1016\/S2214-109X(25)00234-7","volume":"13","author":"H Jiang","year":"2025","unstructured":"Jiang H, Zou H. PrEParing for HIV prevention among men who have sex with men in China: challenges and solutions. Lancet Global Health. 2025;13(9):e1636\u201341.","journal-title":"Lancet Global Health"},{"issue":"7","key":"28479_CR11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1056\/NEJMoa2101016","volume":"385","author":"RJ Landovitz","year":"2021","unstructured":"Landovitz RJ, Donnell D, Clement ME, et al. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. N Engl J Med. 2021;385(7):595\u2013608.","journal-title":"N Engl J Med"},{"issue":"10337","key":"28479_CR12","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0140-6736(22)00538-4","volume":"399","author":"S Delany-Moretlwe","year":"2022","unstructured":"Delany-Moretlwe S, Hughes JP, Bock P, et al. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. Lancet (London England). 2022;399(10337):1779\u201389.","journal-title":"Lancet (London England)"},{"issue":"1","key":"28479_CR13","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1186\/s12889-025-23463-z","volume":"25","author":"R Jiang","year":"2025","unstructured":"Jiang R, Zhang Y, Lu X, et al. Cost-effectiveness of eHealth-based HIV pre-exposure intervention for recreational drugs using among men who have sex with men in China: a modelling study. BMC Public Health. 2025;25(1):3245.","journal-title":"BMC Public Health"},{"issue":"1","key":"28479_CR14","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1186\/s12879-018-3516-8","volume":"18","author":"J Li","year":"2018","unstructured":"Li J, Peng L, Gilmour S, et al. A mathematical model of biomedical interventions for HIV prevention among men who have sex with men in China. BMC Infect Dis. 2018;18(1):600.","journal-title":"BMC Infect Dis"},{"key":"28479_CR15","doi-asserted-by":"crossref","unstructured":"Jin X, Shi L, Wang C et al. Cost-effectiveness of oral pre-exposure prophylaxis and expanded antiretroviral therapy for preventing HIV infections in the presence of drug resistance among men who have sex with men in China: A mathematical modelling study. Lancet Reg Health \u2013 Western Pac 2022;23.","DOI":"10.1016\/j.lanwpc.2022.100462"},{"issue":"2","key":"28479_CR16","doi-asserted-by":"publisher","first-page":"e243","DOI":"10.1016\/S2214-109X(23)00536-3","volume":"12","author":"R Zhao","year":"2024","unstructured":"Zhao R, Fairley CK, Cook AR, et al. Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study and cost-effectiveness analysis. Lancet Global Health. 2024;12(2):e243\u201356.","journal-title":"Lancet Global Health"},{"issue":"9","key":"28479_CR17","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1016\/S2352-3018(18)30097-3","volume":"5","author":"BDL Marshall","year":"2018","unstructured":"Marshall BDL, Goedel WC, King MRF, et al. Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study. Lancet HIV. 2018;5(9):e498\u2013505.","journal-title":"Lancet HIV"},{"issue":"4","key":"28479_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.7326\/M21-1548","volume":"175","author":"AM Neilan","year":"2022","unstructured":"Neilan AM, Landovitz RJ, Le MH, et al. Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States: A Cost-Effectiveness Analysis. Ann Intern Med. 2022;175(4):479\u201389.","journal-title":"Ann Intern Med"},{"issue":"1","key":"28479_CR19","doi-asserted-by":"publisher","first-page":"e70061","DOI":"10.1002\/jia2.70061","volume":"29","author":"JA Heitner","year":"2026","unstructured":"Heitner JA, Stansfield SE, Mitchell KM, et al. Cost-effectiveness of leveraging long-acting injectable cabotegravir to expand PrEP coverage among MSM in two contrasting North American cities. J Int AIDS Soc. 2026;29(1):e70061.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"28479_CR20","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1186\/s12879-025-11960-w","volume":"25","author":"J Lin","year":"2025","unstructured":"Lin J, Xu Y, Ren Y, Shen S. Study on the spatial-temporal evolution and influencing factors of AIDS incidence in China from 2006 to 2022. BMC Infect Dis. 2025;25(1):1690.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"28479_CR21","first-page":"1815","volume":"46","author":"PP Zhong","year":"2025","unstructured":"Zhong PP, Jiang J, Zhou XY, et al. Epidemiological characteristics and influencing factors on mortality of HIV-infected patients in Zhejiang Province, 2003\u20132022. Zhonghua Liu Xing Bing Xue Za Zhi. 2025;46(10):1815\u201322.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"28479_CR22","unstructured":"Prevention JPCfDCa. Progress in Provincial HIV\/AIDS Prevention and Control in 2022. 2022. Accessed 1 Feb 2026."},{"key":"28479_CR23","doi-asserted-by":"publisher","first-page":"101038","DOI":"10.1016\/j.onehlt.2025.101038","volume":"20","author":"Y Tang","year":"2025","unstructured":"Tang Y, Chen Y, Zheng J, et al. Spatio-temporal pattern and risk factors of HIV\/AIDS prevalence in Zhejiang, China, from 2005 to 2022 using R-INLA. One Health. 2025;20:101038.","journal-title":"One Health"},{"issue":"1","key":"28479_CR24","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1186\/s12879-021-06490-0","volume":"21","author":"L Shi","year":"2021","unstructured":"Shi L, Tang W, Hu H, et al. The impact of COVID-19 pandemic on HIV care continuum in Jiangsu, China. BMC Infect Dis. 2021;21(1):768.","journal-title":"BMC Infect Dis"},{"key":"28479_CR25","doi-asserted-by":"publisher","first-page":"1550565","DOI":"10.3389\/fpubh.2025.1550565","volume":"13","author":"L He","year":"2025","unstructured":"He L, Pan X, Yang J, Zheng J, Cheng W, Chai C. HIV transmission risk among people living with HIV in Zhejiang Province, China: data from a large cross-sectional study, 2022. Front Public Health. 2025;13:1550565.","journal-title":"Front Public Health"},{"key":"28479_CR26","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1017\/S0950268820000850","volume":"148","author":"Z Lu","year":"2020","unstructured":"Lu Z, Wang L, Wang LP, et al. A mathematical model for HIV prevention and control among men who have sex with men in China. Epidemiol Infect. 2020;148:e224.","journal-title":"Epidemiol Infect"},{"key":"28479_CR27","doi-asserted-by":"crossref","unstructured":"Wang Y, Tanuma J, Li J et al. Elimination of HIV transmission in Japanese MSM with combination interventions. Lancet Reg Health \u2013 Western Pac 2022;23.","DOI":"10.1016\/j.lanwpc.2022.100467"},{"issue":"5","key":"28479_CR28","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1016\/S2352-3018(15)00020-X","volume":"2","author":"L Zhang","year":"2015","unstructured":"Zhang L, Phanuphak N, Henderson K, et al. Scaling up of HIV treatment for men who have sex with men in Bangkok: a modelling and costing study. Lancet HIV. 2015;2(5):e200\u20137.","journal-title":"Lancet HIV"},{"key":"28479_CR29","first-page":"1191","volume":"21","author":"L Zhou Ying","year":"2017","unstructured":"Zhou Ying L, Jing Z, Zhi, Gengfeng F. Risk factors associated with HIV drug resistance among ART virological failure patients taking first-line antiviral treatment from Jiangsu Province. Chin J Dis Control Prev. 2017;21:1191\u20134.","journal-title":"Chin J Dis Control Prev"},{"issue":"1","key":"28479_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40945-022-00154-1","volume":"12","author":"JH Abbott","year":"2022","unstructured":"Abbott JH, Wilson R, Pryymachenko Y, Sharma S, Pathak A, Chua JYY. Economic evaluation: a reader\u2019s guide to studies of cost-effectiveness. Archives Physiotherapy. 2022;12(1):28.","journal-title":"Archives Physiotherapy"},{"key":"28479_CR31","unstructured":"Statistics ZPBo. Statistical Communiqu\u00e9 of Zhejiang Province on National Economic and Social Development. 2024. 2025; https:\/\/tjj.zj.gov.cn\/art\/2025\/3\/1\/art_1229129205_5469690.html. Accessed 2 Feb 2026."},{"key":"28479_CR32","unstructured":"Statistics JPBo. Statistical Communiqu\u00e9 of Jiangsu Province on National Economic and Social, Development. 2024. 2025; https:\/\/jsnews.jschina.com.cn\/jsyw\/202503\/t20250315_s67d93ac7e4b0eff95f0e35dd.shtml. Accessed 2 Feb 2026."},{"issue":"7","key":"28479_CR33","doi-asserted-by":"publisher","first-page":"e1159","DOI":"10.1016\/S2214-109X(24)00181-5","volume":"12","author":"F Silke","year":"2024","unstructured":"Silke F, Earl L, Hsu J, et al. Cost-effectiveness of interventions for HIV\/AIDS, malaria, syphilis, and tuberculosis in 128 countries: a meta-regression analysis. Lancet Global Health. 2024;12(7):e1159\u201373.","journal-title":"Lancet Global Health"},{"issue":"S2","key":"28479_CR34","doi-asserted-by":"publisher","first-page":"e26109","DOI":"10.1002\/jia2.26109","volume":"26","author":"SE Stansfield","year":"2023","unstructured":"Stansfield SE, Heitner J, Mitchell KM, et al. Population-level impact of expanding PrEP coverage by offering long-acting injectable PrEP to MSM in three high-resource settings: a model comparison analysis. J Int AIDS Soc. 2023;26(S2):e26109.","journal-title":"J Int AIDS Soc"},{"issue":"8","key":"28479_CR35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.7326\/0003-4819-156-8-201204170-00001","volume":"156","author":"JL Juusola","year":"2012","unstructured":"Juusola JL, Brandeau ML, Owens DK, Bendavid E. The Cost-Effectiveness of Preexposure Prophylaxis for HIV Prevention in the United States in Men Who Have Sex With Men. Ann Intern Med. 2012;156(8):541\u201350.","journal-title":"Ann Intern Med"},{"issue":"1","key":"28479_CR36","doi-asserted-by":"publisher","first-page":"14609","DOI":"10.1038\/s41598-020-71565-y","volume":"10","author":"H Choi","year":"2020","unstructured":"Choi H, Suh J, Lee W, et al. Cost-effectiveness analysis of pre-exposure prophylaxis for the prevention of HIV in men who have sex with men in South Korea: a mathematical modelling study. Sci Rep. 2020;10(1):14609.","journal-title":"Sci Rep"},{"issue":"1","key":"28479_CR37","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1186\/s12879-019-4275-x","volume":"19","author":"Q-h Hu","year":"2019","unstructured":"Hu Q-h, Meyers K, Xu J-j, et al. Efficacy and cost-effectiveness of early antiretroviral therapy and partners\u2019 pre-exposure prophylaxis among men who have sex with men in Shenyang, China: a prospective cohort and costing study. BMC Infect Dis. 2019;19(1):663.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"28479_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12916-018-1047-1","volume":"16","author":"M Shen","year":"2018","unstructured":"Shen M, Xiao Y, Rong L, Meyers LA, Bellan SE. The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco. BMC Med. 2018;16(1):58.","journal-title":"BMC Med"},{"key":"28479_CR39","unstructured":"PrEPWatch Global PrEP Tracker \u2013 China. 2026; https:\/\/www.prepwatch.org\/countries\/china. Accessed 4 Mar 2026."},{"issue":"7","key":"28479_CR40","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1007\/s10508-024-02886-6","volume":"53","author":"L Liu","year":"2024","unstructured":"Liu L, Ruan Y, Chen S, et al. Willingness to Use Long-Acting Injectable Cabotegravir and Associated Factors Among Men Who Have Sex with Men in Guangxi, China. Arch Sex Behav. 2024;53(7):2795\u2013806.","journal-title":"Arch Sex Behav"},{"key":"28479_CR41","doi-asserted-by":"crossref","unstructured":"Chen S, Ruan Y, Liu L et al. Willingness to pay and price elasticity of demand for long-acting injectable cabotegravir among men who have sex with men in Guangxi, China. Front Pharmacol 2024;Volume 15\u20132024.","DOI":"10.3389\/fphar.2024.1367830"},{"key":"28479_CR42","unstructured":"GlaxoSmithKline. GlaxoSmithKline\u2019s HIV pre-exposure prophylaxis long-acting drug Eptifibrate (cathelicidin injectable) launched in China. 2025; https:\/\/www.gsk-china.com\/zh-cn\/media\/press-releases\/apretude-launch\/. Accessed 4 Mar 2026."},{"issue":"10485","key":"28479_CR43","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S0140-6736(25)00452-0","volume":"405","author":"L Ryom","year":"2025","unstructured":"Ryom L. The potential for annual long-acting HIV pre-exposure prophylaxis. Lancet (London England). 2025;405(10485):1120\u20131.","journal-title":"Lancet (London England)"},{"issue":"5","key":"28479_CR44","doi-asserted-by":"publisher","first-page":"e1007893","DOI":"10.1371\/journal.pcbi.1007893","volume":"16","author":"CM Hazelbag","year":"2020","unstructured":"Hazelbag CM, Dushoff J, Dominic EM, Mthombothi ZE, Delva W. Calibration of individual-based models to epidemiological data: A systematic review. PLoS Comput Biol. 2020;16(5):e1007893.","journal-title":"PLoS Comput Biol"},{"issue":"7","key":"28479_CR45","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1097\/QAD.0000000000003837","volume":"38","author":"N Georgiadis","year":"2024","unstructured":"Georgiadis N, Papamichail D, Lytras T, et al. The impact of HIV preexposure prophylaxis on bacterial sexually transmitted infection occurrence in MSM: a systematic review and meta-analysis. AIDS. 2024;38(7):1033\u201345.","journal-title":"AIDS"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-28479-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28479-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28479-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:49:40Z","timestamp":1791413380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-28479-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["28479"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-28479-7","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2867"}}